Radiotherapy for Pain

Clinical Oncology

Volumn 23, Issue 6, 2011, Pages 399-406

  Culleton, S ^a   Kwok, S ^a   Chow, E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone metastases; Pain flare; Radiotherapy; Re irradiation; Symptom cluster

Indexed keywords

DEXAMETHASONE;

ARTICLE; BONE METASTASIS; BONE PAIN; BRAIN METASTASIS; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER PREVENTION; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; CORTICOSTEROID THERAPY; DRUG DOSE INCREASE; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION RESPONSE; REIMBURSEMENT; RETREATMENT; SINGLE DRUG DOSE; SPINAL CORD DISEASE; TREATMENT RESPONSE;

BONE NEOPLASMS; HUMANS; PAIN; QUALITY OF LIFE;

EID: 79959717296     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2010.11.011     Document Type: Article

References (55)

1. Chow E., Harris K., Fan G., Tsao M., Sze W. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 2007, 25(11):1423-1436.
2. McQuay H.J., Collins S.L., Carroll D., Moore R.A. Radiotherapy for the palliation of painful bone metastases. Cochrane Database System Rev 2000, (2):001793.
3. Fairchild A., Hird A., Chow E. Chapter 25: Pain control and palliative radiotherapy in bone metastases. Bone cancer 2009, p. 297. Academic Press, New York. D. Heymann (Ed.).
4. McQuay H., Collins S., Carroll D. Radiotherapy for the palliation of painful bone metastases. Cochrane Database System Rev 1999, 3.
5. Ratabatharathorn V., Powers W., Moss W. Bone metastases: review and critical analysis of random allocation trials of local field treatment. Int J Radiat Oncol Biol Phys 1999, 44:1-18.
6. Wu J., Bezjak A., Chow E., Kirkbride P. Primary treatment endpoint following palliative radiotherapy for painful bone metastases: need for a consensus definition?. Clin Oncol 2002, 14:70-77.
7. Chow E., Wu J., Hoskin P., Coia L., Bentzen S., Blitzer P. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 2002, 64:275-280.
8. Sande T., Ruenes R., Lund J., et al. Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: results from a randomised multicentre trial. Radiother Oncol 2009, 91:261-266.
9. Fairchild A., Barnes E., Ghosh S., et al. International patterns of practice in palliative radiotherapy for painful bone metastases: evidence based practice?. Int J Radiat Oncol Biol Phys 2009, 75(5):1501-1510.
10. Chow E., Danjoux C., Wong R., et al. Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologist. Radiol Oncol 2000, 56:305-314.
11. Ben-Josef E., Shamsa F., Williams A., Porter A. Radiotherapeutic management of osseous metastases: a survey of current patterns of care. Int J Radiat Oncol Biol Phys 1998, 40(4):915-921.
12. Koswig S., Budach V. Remineralization and pain relief in bone metastases after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study. Strahlenther Onkol 1999, 175(10):500-508.
13. Flynn C., Yip D., Ko Y., et al. Clinical benefit of reirradiation: a case report. J Palliat Med 2008, 11(1):112-116.
14. Chow E., Hoskin P., Wu J., et al. A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20. Clin Oncol 2006, 18:125-128.
15. Mithal N., Needham P., Hoskin P. Retreatment with radiotherapy for painful bone metastases. Int J Radiat Oncol Biol Phys 1994, 29(5):1011-1014.
16. van der Linden Y., Lok J., Steenland E., Martijn H., Leer J. Re-irradiation of painful bone metastases: a further analysis of the Dutch bone metastasis study. Int J Radiat Oncol Biol Phys 2003, 57(2):S222.
17. Jeremic B., Shibamoto Y., Igrutinovic I. Single 4 Gy re-irradiation for painful bone metastasis following single fraction radiotherapy. Radiother Oncol 1999, 52:123-127.
18. Price P., Hoskin P., Easton D., Austin D., Palmer S., Yarnold J. Low dose single fraction radiotherapy in the treatment of metastastic bone pain: a pilot study. Radiother Oncol 1988, 12:297-300.
19. Hayashi S., Hoshi H., Iida T. Reirradiation with local-field radiotherapy for painful bone metastases. Radiat Med 2002, 20(5):231-236.
20. Jeremic B., Shibamoto Y., Igrutinovic I. Second single 4 Gy reirradiaiton for painful bone metastasis. J Pain Symptom Manage 2002, 23:26-30.
21. Masahiko F., Takyju T., Wakako S., Masahilko O., Takashi Y. Reirradiation for vertebral metastasis of the breast cancer. Japan J Clin Radiol 2000, 45(10):1161-1163.
22. Hird A., Zhang L., Holt T., et al. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study. Clin Oncol 2009, 21(4):329-335.
23. Schoeneich G., Palmedo H., Dierke-Dzierzon C., Muller S.C., Biersack H.J. Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results. Scand J Urol Nephrol 1997, 31(5):445-448.
24. Silberstein E. Teletherapy and radiopharmaceutical therapy of painful bone metastases. Semin Nucl Med 2005, 35(2):152-158.
25. Slovin S., Scher H., Divgi C., et al. Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer. Clin Cancer Res 1998, 4(3):643-651.
26. Roka R., Sera T., Pajor L., et al. Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain. Orv Hetil 2000, 141(19):1019-1023.
27. de Klerk J., van het Schip A., Zonnenberg B., et al. Phase I study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer. J Nucl Med 1996, 37(2):244-249.
28. Dafermou A., Colamussi P., Giganti M., Cittanti C., Bestagno M., Piffanelli A. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer. Eur J Nucl Med 2001, 28(7):788-798.
29. Kraeber-Bodere F., Campion L., Rousseau C., Bourdin S., Chatal J., Resche I. Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement. Eur J Nucl Med 2000, 27(10):1487-1493.
30. Limouris G., Shukla S., Condi-Paphiti A., et al. Palliative therapy using rhenium-186-HEDP in painful breast osseous metastases. Anticancer Res 1997, 17(3B):1767-1772.
31. Foro P., Algara M., Reig A., Lacruz A., Valls A. Randomized prospective trial comparing three schedules of palliative radiotherapy. Oncologia 1999, 21:55-60.
32. Loblaw D., Wu J., Kirkbride P., et al. Pain flare in patients with bone metastases after palliative radiotherapy-a nested randomized control trial. Support Care Cancer 2007, 15(4):451-455.
33. Chow E., Ling A., Davis L., Panzarella T., Danjoux C. Pain flare following external beam radiotherapy and meaningful change in pain scores in the treatment of bone metastases. Radiother Oncol 2005, 75(1):64-69.
34. Roos D., Turner S., O'Brien P., et al. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 2005, 75(1):54-63.
35. Hird A., Chow E., Zhang L., et al. Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three Canadian cancer centers. Int J Radiat Oncol Biol Phys 2009, 75(1):193-197.
36. Hird A., Wong R., Flynn C., et al. Impact of pain flare on patients treated with palliative radiotherapy for symptomatic bone metastases. J Pain Manage 2009, 2(4):401-406.
37. Chow E., Loblaw D., Harris K., et al. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases-a pilot study. Support Care Cancer 2007, 15:643-664.
38. Chang V., Hwang S., Feuerman M., Kasimis B. Symptom and quality of life survey of medical oncology patients at a Veterans affairs medical center: a role for symptom assessment. Cancer 2000, 88(5):1175-1183.
39. Portenoy R., Thaler H., Kornblith A., et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 1994, 3(3):183-189.
40. Barsevick A., Whitmer K., Nail L., Beck S., Dudley W. Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage 2006, 31(1):85-95.
41. Walsh D., Rybicki L. Symptom clustering in advanced cancer. Support Care Cancer 2006, 14(8):831-836.
42. Miaskowski C., Dodd M., Lee K. Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monographs 2004, 32:17-21.
43. Dodd M., Miaskowski C., Paul S. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 2001, 28(3):465-470.
44. Kim H., McGuire D., Tulman L., Barsevick A. Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs 2009, 28(4):270-282. 283-284.
45. Fan G., Filipczak L., Chow E. Symptom clusters in cancer patients: a review of the literature. Curr Oncol 2007, 14(5):173-179.
46. Fan G., Hadi S., Chow E. Symptom clusters in patients with advanced-stage cancer referred for palliative radiation therapy in an outpatient setting. Support Cancer Ther 2007, 4(3):157-162.
47. Kirkova J., Walsh D. Cancer symptom clusters-a dynamic construct. Support Care Cancer 2007, 15(9):1011-1013.
48. Chow E., Fan G., Hadi S., Filipczak L. Symptom clusters in cancer patients with bone metastases. Support Care Cancer 2007, 15(9):1035-1043.
49. Hadi S., Fan G., Hird A., Kirou-Mauro A., Filipczak L., Chow E. Symptom clusters in patients with cancer with metastatic bone pain. J Palliat Med 2008, 11(4):591-600.
50. Cleeland C., Bennett G., Dantzer R., et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003, 97(11):2919-2925.
51. Niv D., Shulamith K. Pain and quality of life. Pain Med 2001, 1(2):150-161.
52. Wang X., Cleeland C., Mendoza T., et al. The effects of pain severity on health-related quality of life: a study of Chinese cancer patients. Cancer 1999, 86:1848-1855.
53. Hird A., Chow E. Chapter 18: Outcome measures in bone metastases clinical trials. Bone metastases (A translational and clinical approach) 2009, 12:371-394. D. Kardamakis, V. Vassiliou, E. Chow (Eds.).
54. Bezjak A., Ng P., Taylor K., Macdonald K., Depetrillo A. A preliminary survey of oncologists' perceptions of quality of life information. Psychooncology 1997, 6:107-113.
55. Chow E., Hird A., Velikova G., et al. EORTC Quality of Life Group. The European Organisation for Research and Treatment of Cancer quality of life questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer 2009, 45(7):1146-1152.